PAXLOVID β PFIZER, approved 2026-02-11 (NDA217188).
72,800 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System β they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.